Therapeutic white blood cell and platelet depletions using the spectra OPTIA system continuous mononuclear cell protocol
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21644
Abstract: The Spectra Optia apheresis system has only recently been approved by the Food and Drug Administration (FDA) for therapeutic white blood cell (WBC) depletions and is not yet approved for platelet depletions. Prior to FDAâapproval… read more here.
Keywords: platelet depletions; protocol; spectra optia; cell ... See more keywords